Generic Protocols for the Analytical Validation of cfDNA Assays Working Group

Angela Silvestro

Director, Companion Diagnostics

GSK

Co-Chairs

Jim Godsey

Scientific Co-chair

BLOODPAC

Current Projects

Paper - Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: Version 2.0

Participating Organizations

AstraZeneca, Bio-Rad, Bristol Myers Squibb (BMS), Freenome, GSK, Guardant Health, Illumina, Labcorp, Labcorp, Streck, Tempus, University of Arkansas for Medical Sciences (UAMS), University of Southern California (USC)

Past Deliverables

September 2020: Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC’s Analytical Variables Working Group

Meetings

This working group meets on zoom every other Thursday from 3:30 - 5:00 PM EST.

Special workshops and sessions:

Not applicable at this time.